Skip to main content

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Margarita Navarro Pérez

Margarita Navarro Pérez

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Manuel Alanis Bernal

Manuel Alanis Bernal

Research technician
Research Group on Status Epilepticus and Acute Seizures
Read more
Guillem Pons Barcons

Guillem Pons Barcons

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Amarilis Sofia Baekelandt

Amarilis Sofia Baekelandt

Predoctoral researcher
Cardiovascular Diseases
Read more
Miriam Barrecheguren Fernández

Miriam Barrecheguren Fernández

Main researcher
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.